• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

News & Events

  • Print
  • Share
  • E-mail

Public Calendar: December 17-21, 2012

This public calendar is issued by the Food and Drug Administration. It lists significant meetings held by designated FDA policy makers with persons outside the executive branch of the Federal Government.

December 17-21, 2012
FDA Official and TitleDateLocationOther FDA ParticipantsNon-FDA ParticipantsSubject
Margaret A. Hamburg, M.D., Commissioner of Food and Drugs12/19/12Silver Spring, MDN/AN/APublic Meeting entitled "Framework for Pharmacy Compounding:  State and Federal Roles"
Margaret A. Hamburg, M.D., Commissioner of Food and Drugs12/19/12Silver Spring, MDLisa Barclay, Peter Lurie, Virginia Cox, Doug Throckmorton, Denise Esposito, Emily Thakur, Maryll Toufanian, Steve Kozlowski, Candra Smith, Michelle Williams-EllerbeRalph G. Neas, David Gaugh, Jim Fenton, Christine Simmon (Generic Pharmaceutical Association)Biological Product Naming and Accelerated Recovery Initiative (ARI)
John M. Taylor, III, J.D., Counselor to the Commissioner12/17/12-12/21/12N/AN/AN/ANo Significant Meetings
Deborah M. Autor, Esq., Deputy Commissioner for Global Regulatory Operations and Policy12/17/12-12/21/12N/AN/AN/ANo Significant Meetings
Virginia Cox, Associate Commissioner for External Affairs12/17/12-12/21/12N/AN/AN/ANo Significiant Meetings
Lawrence Deyton, M.S.P.H., M.D., Director, Center for Tobacco Products12/17/12-12/21/12N/AN/AN/ANo Significant Meetings
Elizabeth H. Dickinson, Esq., Chief Counsel12/17/12-12/21/12N/AN/AN/ANo Significant Meetings
Bernadette Dunham, D.V.M., Ph.D., Director, Center for Veterinary Medicine12/18/12Rockville, MDN/AN/AAnimal Drug User Fee Act/Animal Generic Drug User Fee Act Public Meeting
Bernadette Dunham, D.V.M., Ph.D., Director, Center for Veterinary Medicine12/18/12Rockville, MDWilliam Flynn, Tracey Forfa, Nadine Steinberg, Dan McChesneyRich Carnevale, Kent McClure, Ron Phillips, Sam Veluvolu (Animal Health Institute)Drug Approval Process
Jesse Goodman, M.D., M.P.H., Chief Scientist12/17/12-12/21/12N/AN/AN/ANo Significant Meetings
Walter Harris, Chief Operating Officer12/17/12-12/21/12N/AN/AN/ANo Significant Meetings
Michael M. Landa, Director, Center for Food Safety and Applied Nutrition12/17/12-12/21/12N/AN/AN/ANo Significant Meetings
Peter Lurie, Acting Associate Commissioner for Policy and Planning12/17/12-12/21/12N/AN/AN/ANo Significant Meetings
Karen Midthun, M.D., Director, Center for Biologics Evaluation and Research12/17/12-12/21/12N/AN/AN/ANo Significant Meetings
Michele Mital, Acting Associate Commissioner for Legislation12/17/12-12/21/12N/AN/AN/ANo Significant Meetings
Melinda Plaiser, Acting Associate Commissioner for Regulatory Affairs12/17/12-12/21/12 N/AN/AN/ANo Significant Meetings
Jeffrey Shuren, M.D., J.D., Director, Center for Devices and Radiological Health12/17/12-12/21/12N/AN/AN/ANo Significant Meetings
William Slikker, Jr., Ph.D., Director, National Center for Toxicological Research12/17/12-12/21/12N/AN/AN/ANo Significant Meetings
Stephen Spielberg, M.D., Ph.D., Deputy Commissioner for Medical Products and Tobacco12/17/12-12/21/12N/AN/AN/ANo Significant Meetings
Michael R. Taylor, J.D., Deputy Commissioner for Foods, Office of Foods12/19/12Washington, DCMary Lou Valdez, Sema Hashema, Camille BrewerAmbassador Y.J. Choi (South Korean Embassy)South Korean Shellfish Sanitation Program
Michael R. Taylor, J.D., Deputy Commissioner for Foods, Office of Foods12/21/12Silver Spring, MDRebecca BucknerSharon Bomer (Office of the United States Trade Representative)Food Safety Modernization Act
Mary Lou Valdez, Associate Commissioner for International Programs12/17/12-12/21/12N/AN/AN/ANo Significant Meetings
Jill Hartzler Warner, J.D., Acting Associate Commissioner for Special Medical Programs12/18/12Silver Spring, MDMargaret Renner, Rosanne Hurwitz, Amanda Edmonds, John Thomas, Laurie LenkelKathleey Beauchamp, Andrew Green (Halscion, Inc.); Jeffrey Shapiro, Jeffrey Gibbs (Hyman Phelps & McNamara)Product Matter
Janet Woodcock, M.D., Director, Center for Drug Evaluation and Research12/18/12Silver Spring, MDN/ARobert Pearl (Permanente Medical Group); Oxana Pickerall (Booz Allen); Sachi Jain (Merck); Phyllis Greenberger (Society for Women’s Health Research)Biomedical Research and Development
Janet Woodcock, M.D., Director, Center for Drug Evaluation and Research12/19/12Washington, DCN/AHarvey V. Fineberg (Institute of Medicine); Freda Lewis-Hall (Pfizer); Clay Johnston (University of California-San Francisco); Ana Pujols McKee (The Joint Commission); Rebecca Li (Harvard) Institute of Medicine: Developing a National Certification System to Improve Clinical Trial Performance